Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Not yet recruiting1
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

unknown125%
not_yet_recruiting125%
terminated125%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruiting

Anxiety & Depression in Thyroid Cancer Patients

NCT06269731
unknownnot_applicable

In Vivo Investigation on Mitochondrial Dysfunction in Post-COVID Fatigue and Cancer Fatigue.

NCT05753228
completed

Voice Biomarkers Predictive of Depression and Anxiety

NCT05455905
terminated

Affective Processing in Depression and Epilepsy

NCT00855725

Clinical Trials (4)

Showing 4 of 4 trials
NCT06269731

Anxiety & Depression in Thyroid Cancer Patients

Not Yet Recruiting
NCT05753228Not Applicable

In Vivo Investigation on Mitochondrial Dysfunction in Post-COVID Fatigue and Cancer Fatigue.

Unknown
NCT05455905

Voice Biomarkers Predictive of Depression and Anxiety

Completed
NCT00855725

Affective Processing in Depression and Epilepsy

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4